Profile data is unavailable for this security.
About the company
Sigachi Industries Limited is an India-based pharmaceutical company delivering excipients, vitamin mineral nutrient blends, active pharmaceutical ingredients (APIs), and operations and maintenance (O&M) services. The Company is engaged in manufacturing of micro crystalline cellulose powder (MCCP). It services various industries, including pharmaceutical, food and nutraceutical, cosmetic, and chemical. In the pharmaceutical industry, the Company's products have applications in API, pre-formulated excipients, high functionality excipients, thickeners/ stabilizers, binders, super disintegrants, carriers, lubricants and nutraceutical formulations. In the food and nutraceutical industry, its products have applications in nutrition, ready-to-use additives, stabilizers and dietary fiber. In the cosmetic industry, its products have applications in skin care, hair care and toiletry. In the chemical industry, the Company's cellulose products are used in electrodes, and as filter aid.
- Revenue in INR (TTM)4.36bn
- Net income in INR660.99m
- Incorporated1989
- Employees991.00
- LocationSigachi Industries LtdKalyans Tulsi Ram Chambers,HYDERABAD 500049IndiaIND
- Phone+91 4 040114874
- Fax+91 4 040216248
- Websitehttps://www.sigachi.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ngl Fine Chem Ltd | 3.72bn | 413.64m | 11.10bn | 390.00 | 26.84 | 3.96 | 29.18 | 2.99 | 66.95 | 66.95 | 601.51 | 453.70 | 1.03 | 4.37 | 5.12 | 9,529,503.00 | 11.51 | 15.06 | 14.90 | 19.58 | 51.59 | 43.53 | 11.13 | 13.15 | 2.17 | 25.70 | 0.1594 | 3.06 | 21.79 | 17.20 | 101.58 | 15.47 | 14.49 | 0.00 |
| Bajaj Healthcare Ltd | 5.08bn | -101.06m | 12.14bn | 944.00 | -- | 2.72 | 67.12 | 2.39 | -3.70 | -5.69 | 183.39 | 141.16 | 0.6186 | 1.54 | 2.33 | 5,379,316.00 | -1.23 | 7.67 | -2.35 | 14.11 | 47.51 | 33.26 | -1.99 | 7.99 | 1.21 | 1.95 | 0.3158 | 4.90 | -26.69 | 5.04 | -122.55 | -- | 15.08 | -- |
| Lincoln Pharmaceuticals Ltd | 5.97bn | 966.39m | 12.36bn | 1.70k | 12.79 | 1.93 | 11.38 | 2.07 | 48.25 | 48.25 | 298.31 | 319.16 | 0.828 | 3.77 | 3.40 | 3,514,339.00 | 13.39 | 13.95 | 15.85 | 16.54 | 52.60 | 50.65 | 16.18 | 14.71 | 3.64 | 60.48 | 0.0021 | 3.44 | 13.76 | 9.66 | 27.99 | 13.88 | 21.54 | 3.71 |
| Bliss GVS Pharma Ltd | 8.00bn | 634.20m | 13.59bn | 831.00 | 21.72 | 1.34 | 13.65 | 1.70 | 5.94 | 5.94 | 75.55 | 96.05 | 0.6454 | 3.10 | 1.98 | 9,628,987.00 | 5.80 | 6.46 | 7.04 | 8.22 | 50.26 | 43.91 | 8.99 | 9.92 | 3.74 | -- | 0.0825 | 7.92 | 2.48 | -3.03 | 6.49 | -9.42 | -8.33 | -12.94 |
| Remus Pharmaceuticals Ltd | 2.12bn | 215.37m | 13.79bn | 48.00 | 62.68 | 15.87 | 51.31 | 6.49 | 37.34 | 37.34 | 374.91 | 147.42 | 1.46 | 7.61 | 3.56 | 44,270,750.00 | 17.80 | -- | 44.48 | -- | 22.67 | -- | 12.22 | -- | 1.12 | 55.56 | 0.0997 | -- | 371.94 | -- | 153.29 | -- | -- | -- |
| Zota Health Care Ltd | 2.20bn | -346.82m | 14.54bn | 445.00 | -- | 9.14 | -- | 6.60 | -13.20 | -13.20 | 84.28 | 59.92 | 0.8794 | 2.11 | 7.20 | 4,947,045.00 | -13.89 | -1.38 | -17.57 | -1.85 | 51.96 | 35.95 | -15.79 | -1.33 | 0.8357 | -3.46 | 0.3966 | -- | 28.96 | 16.08 | -148.54 | -- | 39.85 | 0.00 |
| Jagsonpal Pharmaceuticals Ltd | 2.27bn | 243.00m | 15.71bn | 1.03k | 66.02 | 7.96 | 55.08 | 6.93 | 8.98 | 8.98 | 83.78 | 74.42 | 0.9703 | 5.13 | 9.92 | 2,213,181.00 | 10.39 | 10.95 | 12.40 | 13.29 | 58.16 | 58.13 | 10.71 | 9.21 | 2.60 | 32.84 | 0.0474 | 43.81 | -11.83 | 4.58 | -15.94 | 25.50 | -35.69 | 82.06 |
| Sigachi Industries Ltd | 4.36bn | 660.99m | 15.91bn | 991.00 | 28.30 | 3.37 | 20.46 | 3.65 | 1.69 | 1.69 | 11.11 | 14.15 | 0.6266 | 3.01 | 3.27 | 4,396,491.00 | 9.36 | 14.77 | 13.25 | 19.57 | 50.50 | 50.30 | 14.93 | 14.92 | 1.39 | 6.47 | 0.2576 | 1.61 | 32.08 | 25.34 | 31.34 | 24.64 | 70.35 | -- |
| JG Chemicals Ltd | 7.57bn | 550.05m | 17.03bn | 56.00 | 29.43 | 3.90 | 27.30 | 2.25 | 14.77 | 14.77 | 202.34 | 111.33 | -- | -- | -- | 135,230,700.00 | -- | -- | -- | -- | 17.29 | -- | 7.56 | -- | 11.46 | -- | 0.0281 | -- | -14.90 | -- | -43.84 | -- | -- | -- |
| Syncom Formulations (India) Ltd | 3.29bn | 331.47m | 18.58bn | 802.00 | 48.70 | 5.93 | 48.28 | 5.64 | 0.406 | 0.406 | 3.49 | 3.34 | 0.8485 | 6.21 | 3.62 | 4,105,761.00 | 8.54 | 7.50 | 10.99 | 10.23 | 38.49 | 34.10 | 10.07 | 9.38 | 4.09 | 12.05 | 0.0435 | -- | 17.45 | 7.12 | 26.13 | 17.95 | -- | -- |
| Beta Drugs Ltd | 3.35bn | 410.00m | 19.06bn | 371.00 | 46.50 | 10.54 | 37.34 | 5.70 | 42.65 | 42.65 | 348.21 | 188.13 | 1.26 | 4.04 | 3.74 | 9,022,873.00 | 15.42 | 15.10 | 23.35 | 22.23 | 39.95 | 39.77 | 12.25 | 12.38 | 1.59 | 17.06 | 0.0953 | 0.00 | 30.21 | 35.01 | 18.62 | 35.29 | -10.89 | -- |
| Windlas Biotech Ltd | 6.96bn | 612.28m | 19.37bn | 1.15k | 31.73 | 4.11 | 23.95 | 2.78 | 29.20 | 29.20 | 331.88 | 225.63 | 1.06 | 6.07 | 4.43 | 6,028,180.00 | 9.30 | -- | 13.64 | -- | 37.52 | -- | 8.80 | -- | 1.61 | 30.61 | 0.0388 | -- | 22.97 | -- | 36.51 | -- | -- | -- |
| IOL Chemicals and Pharmaceuticals Ltd. | 20.72bn | 1.19bn | 20.06bn | 2.78k | 16.92 | -- | 10.85 | 0.9683 | 20.20 | 20.20 | 353.05 | -- | -- | -- | -- | 7,461,253.00 | -- | 14.91 | -- | 19.45 | 33.96 | 34.54 | 5.72 | 12.00 | -- | 10.06 | -- | 10.59 | -3.80 | 4.82 | -3.39 | -10.70 | 35.27 | -- |
| SMS Pharmaceuticals Ltd | 7.68bn | 593.38m | 20.26bn | 1.20k | 34.05 | 3.59 | 22.14 | 2.64 | 7.03 | 7.03 | 91.03 | 66.57 | 0.7278 | 1.81 | 4.18 | 6,420,048.00 | 5.55 | 5.43 | 8.40 | 7.33 | 30.10 | 33.30 | 7.62 | 7.87 | 0.7104 | 4.54 | 0.3361 | 6.17 | 35.86 | 8.81 | 805.82 | 4.47 | 8.41 | 9.86 |
| Hester Biosciences Ltd | 3.12bn | 234.69m | 20.26bn | 642.00 | 83.96 | 6.71 | 48.11 | 6.49 | 28.37 | 28.37 | 368.62 | 354.81 | 0.4617 | 1.22 | 3.23 | 4,862,882.00 | 3.89 | 6.15 | 4.91 | 7.69 | 71.13 | 66.64 | 8.42 | 12.83 | 1.22 | 2.85 | 0.4371 | 23.27 | 14.45 | 11.33 | -29.06 | -14.59 | 1.49 | -11.42 |
| Amrutanjan Health Care Ltd | 4.38bn | 475.20m | 20.39bn | 635.00 | 42.95 | 6.85 | 37.85 | 4.66 | 16.43 | 16.43 | 151.37 | 103.00 | 1.19 | 6.89 | 12.85 | 6,893,025.00 | 12.88 | 16.22 | 16.48 | 20.12 | 50.03 | 53.09 | 10.86 | 13.23 | 3.62 | 217.88 | 0.0074 | 18.95 | 10.96 | 10.71 | 12.90 | 12.46 | 26.93 | 16.43 |
Data as of Nov 22 2024. Currency figures normalised to Sigachi Industries Ltd's reporting currency: Indian Rupee INR
0.05%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| SSgA Funds Management, Inc.as of 07 Nov 2024 | 155.79k | 0.05% |
| Motilal Oswal Asset Management Co. Ltd.as of 31 Oct 2024 | 3.48k | 0.00% |
| Bandhan AMC Ltd.as of 31 Oct 2024 | 2.15k | 0.00% |
Data from 30 Sep 2024 - 31 Oct 2024Source: FactSet Research Systems Inc.
